Skip to main content
OpenTrials

Clinical trial condition

Oppositional Defiant Disorder

Explore clinical trials studying Oppositional Defiant Disorder. Study availability and eligibility vary by location and protocol.

75 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Oppositional Defiant Disorder trial results

Completed

Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder

NCT00228046

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +4 more
Locations
  • Long Island Jewish Medical Center / Schneider Children's Hospital New Hyde Park, New York, United States
  • Stony Brook University Hospital Stony Brook, New York, United States
View Trial Details
Completed

Resources to Enhance the Adjustment of Children (REACH)

NCT00820001

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +4 more
Locations
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Bellefield Towers - Western Psychiatric Institute and Clinic Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Parent Training to Promote Early Identification and Treatment of Childhood Behavioral Disorders

NCT00402857

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +3 more
Locations
  • MGH Chelsea Healthcare Center Chelsea, Massachusetts, United States
  • Codman Square Health Center Dorchester, Massachusetts, United States
  • Martha Eliot Health Center Jamaica Plain, Massachusetts, United States
  • Medical Associates Pediatrics Leominster, Massachusetts, United States
View Trial Details
Completed

Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany

NCT00406354

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Düsseldorf, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fulda, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany
View Trial Details
Completed

An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).

NCT00192023

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Alessandria, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Bari, Italy
  • For additional Information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician Cagliari, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Genova, Italy
View Trial Details

Related conditions